Neuronetics (STIM) Income from Continuing Operations (2017 - 2026)
Neuronetics (STIM) reported Income from Continuing Operations of 11261000.0 for Q1 2026, up 11.43% year-over-year from 10106046.02 in Q1 2025, and down 41.51% quarter-over-quarter from 7958000.0 in Q4 2025.
Neuronetics (STIM) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Income from Continuing Operations data on file, last reported at 11261000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 11261000.0, up 11.43% year-over-year; the trailing twelve-month figure through Mar 2026 was 38773000.0 (up 15.26% YoY), and the FY2025 annual result was 39851000.0, up 4.77% from the prior year.
- Income from Continuing Operations slipped to 11261000.0 in Q1 2026 per STIM's latest filing, from 7958000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 6271000.0 in Q4 2023 and troughed at 13229000.0 in Q4 2024.
- A 5-year average of 9878235.29 and a median of 10027000.0 in 2025 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations tumbled 110.96% in 2024, then jumped 39.84% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 8827000.0 in 2022, then increased by 28.96% to 6271000.0 in 2023, then plunged by 110.96% to 13229000.0 in 2024, then surged by 39.84% to 7958000.0 in 2025, then slumped by 41.51% to 11261000.0 in 2026.
- Business Quant data shows STIM's Income from Continuing Operations at 11261000.0 in Q1 2026, 7958000.0 in Q4 2025, and 9527000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Neuronetics | 2.40 Mn | -7.28 Mn | 16.15 Mn | -11.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.26 Mn |
| Dec 31, 2025 | -7.96 Mn |
| Sep 30, 2025 | -9.53 Mn |
| Jun 30, 2025 | -10.03 Mn |
| Mar 31, 2025 | -12.71 Mn |
| Dec 31, 2024 | -13.23 Mn |
| Sep 30, 2024 | -9.33 Mn |
| Jun 30, 2024 | -10.49 Mn |
| Mar 31, 2024 | -8.69 Mn |
| Dec 31, 2023 | -6.27 Mn |
| Sep 30, 2023 | -10.06 Mn |
| Jun 30, 2023 | -8.49 Mn |
| Mar 31, 2023 | -11.01 Mn |
| Dec 31, 2022 | -8.83 Mn |
| Sep 30, 2022 | -8.35 Mn |
| Jun 30, 2022 | -10.60 Mn |
| Mar 31, 2022 | -11.11 Mn |
| Dec 31, 2021 | -7.97 Mn |
| Sep 30, 2021 | -8.18 Mn |
| Jun 30, 2021 | -7.54 Mn |